Merck Serono and Ablynx Enter Into an Agreement to Co-Discover and Co-Develop Nanobodies.: An article from: BIOTECH Patent News

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on September 1, 2008. The length of the article is 882 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Merck Serono and Ablynx Enter Into an Agreement to Co-Discover and Co-Develop Nanobodies.
Author: Gale Reference Team
Publication:BIOTECH Patent News (Newsletter)
Date: September 1, 2008
Publisher: Biotech Patent News
Volume: 22 Issue: 9

Distributed by Gale, a part of Cengage Learning